In a previous post, I raised the question of biotechs and emerging markets. Glenmarkparma came to my attention because of its recent deal with DYAX. Looks like Glenmark is targeting emerging markets and is pursuing biologics. Does anyone here know anything about Glenmark or any of its programs?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.